Medication info
Ebsimbajung 10/20 mg

Ebsimbajung 10/20 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
White to near-white, double convex rectangular tablet
Packaging
30 tablets (10 tablets/Alu-Alu x 3)
Approval status
Active

MFDS item code 201803738 · Approved 2018.09.17

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this medicine is 10/10mg to 10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. For patients who require only a small reduction in LDL cholesterol, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Hepatic Dysfunction under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary for elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps reduce elevated total cholesterol, LDL cholesterol, ApoB protein, and triglycerides in patients with primary hypercholesterolemia and mixed hyperlipidemia, and increases HDL cholesterol (the good cholesterol). It is used as an adjunct therapy, especially in patients with familial hypercholesterolemia or when dietary measures alone are insufficient. This medication is used in conjunction with an appropriate diet and is administered when dietary measures do not provide sufficient effect. It is important to identify and address causes of dyslipidemia, such as diabetes and hypothyroidism, before use. Additionally, during treatment, regular management of cholesterol and triglyceride levels contributes to reducing cardiovascular disease risk. In summary, this medication is used to improve blood lipid levels associated with hypercholesterolemia and support cardiovascular health.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this medicine is 10/10mg to 10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. For patients who require only a small reduction in LDL cholesterol, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Hepatic Dysfunction under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary for elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is helpful in reducing blood cholesterol levels. Muscle issues can occur, so if muscle pain or weakness appears, notify your doctor immediately. Especially when taking high doses or in conjunction with certain medications, the risk of myopathy or rhabdomyolysis may increase. Women who are pregnant or breastfeeding should not take this medication, and women planning to become pregnant should consult with their doctor. It is advisable not to use this medication if liver function is impaired or if there are liver diseases. Furthermore, this medication can interact with certain medications, so if taking other drugs, it is essential to inform your doctor or pharmacist. Caution is also needed for the elderly, children, and adolescents, and regular blood tests to check liver and muscle status are important. There is no specific antidote for overdose, so appropriate treatment must be given according to symptoms. When taking this medication, avoid grapefruit juice or certain medications, and consult healthcare professionals immediately if new symptoms arise.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 102 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • drug-induced liver injury
  • asthenia
  • cataracts
  • constipation
  • dyspepsia
  • flatus
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • oculomotor dysfunction
  • facial paresis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • memory impairment
  • forgetfulness
  • amnesia
  • cognitive dysfunction
  • confusion
  • interstitial lung disease
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestasis jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • elevated serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best to store it at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the medication’s effectiveness and prevent deterioration.

Appearance and packaging

Appearance

White to near-white, double convex rectangular tablet

Package unit

30 tablets (10 tablets/Alu-Alu x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.